Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
Insulet (PODD) Zacks Investment Research·2024-04-13 01:16财务表现 - Insulet (PODD)是一家医疗产品行业的公司，过去两个季度平均超出盈利预期达到93.23%[2] - Insulet上个季度每股盈利为$1.40，远高于Zacks Consensus Estimate的$0.67，超出预期达到108.96%[3] - Insulet目前的Earnings ESP为+11.11%，结合Zacks Rank 2 (Buy)，预示着公司可能会再次超出盈利预期[8]